# Markus Warmuth: Eliminating Pathogenic Proteins with Molecular Glue Degraders

Page: https://stenobird.com/podcast/behind-the-breakthroughs-7055075/markus-warmuth-eliminating-pathogenic-proteins-with-molecular-glue-degraders
Text version: https://stenobird.com/podcast/behind-the-breakthroughs-7055075/markus-warmuth-eliminating-pathogenic-proteins-with-molecular-glue-degraders.md
Podcast: [Behind the Breakthroughs](https://stenobird.com/podcast/behind-the-breakthroughs-7055075)
Published: 2026-03-11T07:01:00+00:00
Episode link: https://shows.acast.com/behind-the-breakthroughs-by-inside-precision-medicine/episodes/markus-warmuth-eliminating-pathogenic-proteins-with-molecula
Audio file: https://sphinx.acast.com/p/open/s/67105af848726944170ab1fe/e/69ab36ebb49eecc0b7c39b2a/media.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/behind-the-breakthroughs-7055075/episodes/markus-warmuth-eliminating-pathogenic-proteins-with-molecular-glue-degraders
Duration seconds: 2903

## Resource

Traditional drugs usually inhibit specific protein sites, but many disease-causing proteins lack accessible or unique motifs, leaving them “undruggable.” Targeted Small-molecule drugs have long been the quiet workhorses of modern medicine, slipping inside cells to target disease-driving proteins, even as biologics, immunotherapies, and genetic medicines have taken center stage in recent years. Yet thousands of disease-related proteins remain “undruggable” because they lack the structural pockets needed for traditional inhibitors to bind. In this episode, Markus Warmuth, MD, CEO of Monte Rosa Therapeutics, explains how molecular glue degraders harness the cell’s protein-disposal machinery to eliminate harmful proteins entirely, and how the company’s QUEEN discovery platform is advancing new therapies in cancer and autoimmune disease. Produced and hosted by Jonathan D. Grinstein, PhD Audio mixed and mastered by Erick Ziegler Brought to you by Inside Precision Medicine (SAGE Publishing) Hosted on Acast. See acast.com/privacy for more information.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/behind-the-breakthroughs-7055075/episodes/markus-warmuth-eliminating-pathogenic-proteins-with-molecular-glue-degraders/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/behind-the-breakthroughs-7055075/markus-warmuth-eliminating-pathogenic-proteins-with-molecular-glue-degraders.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.